Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial - Concepedia

Concepedia

Publication | Open Access

Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial

DOI Full Paper Access

134

Citations

32

References

2022

Year

Dean Follmann, Holly Janes, Olive D. Buhule, Bethany Girard, Kristen Marks, Karen L. Kotloff, Michaël Desjardins, Lawrence Corey, Kathleen M. Neuzil, Jacqueline M. Miller,

Annals of Internal Medicine

Abstract

National Institute of Allergy and Infectious Diseases of the National Institutes of Health.

References

	Year	Citations

Page 1